Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
Lucid Diagnostics priced an $18 million registered direct offering of 18 million common shares at $1.00 per share. The raise is anchored by a $15 million investment from a fundamental institutional investor with support from an existing shareholder.
Key figures
- Deal Value Usd
- 18000000
- Offering Price
- 1
- Shares Offered
- 18000000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.